Jan 8 - Fitch Ratings has published its 'U.S. Healthcare Stats Quarterly'
report for the third quarter of 2012.
The report provides a summary of the operating performance and credit metrics of
the companies in this sector over the past four years. It includes
company-specific key credit strengths and concerns and a summary of the
companies' liquidity positions, including debt maturities, as of the end of the
third quarter of 2012. Aggregated credit trends and uses of cash are depicted in
more than 50 charts, and a summary of Fitch's latest ratings changes are also
The report is available on the Fitch web site at 'www.fitchratings.com.'
Additional information is available at 'www.fitchratings.com'.
Applicable Criteria and Related Research:
--'2013 Outlook: Global Pharmaceuticals' Dec. 13, 2012;
--'2013 Outlook: U.S. Healthcare - Navigating a Dynamic Operating and Regulatory
Environment' Nov. 29, 2012.
Navigating the Drug Channel
--'The ABCs (and Ds) of Drug Pricing' July 25, 2012.
--'Global Pharmaceutical R&D Pipeline: First Quarter 2012' July 25, 2012.
--'U.S. Leveraged Finance Spotlight Series: HCA Holdings, Inc.' Oct. 24, 2012;
--'U.S. Leveraged Finance Spotlight Series Community Health Systems, Inc.' Oct.
--'Hospitals Credit Diagnosis: Second Quarter 2012' Sept. 18, 2012.
Applicable Criteria and Related Research: U.S. Healthcare Stats Quarterly -
2013 Outlook: Global Pharmaceuticals
2013 Outlook: U.S. Healthcare -- Navigating a Dynamic Operating and Regulatory
Global Pharmaceutical R&D Pipeline: First-Quarter 2012
U.S. Leveraged Finance Spotlight Series: HCA Holdings, Inc.
U.S. Leveraged Finance Spotlight Series Community Health Systems, Inc.
Hospitals Credit Diagnosis: Operating Trends Remain Weak but Solid Liquidity
Supports Credit Profiles